Position in NUVB
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,932,200
-$3,225,360 QoQ
Shares Held
683,497
-0.5% QoQ
Ownership
0.196%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. NUVB ranks #110 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in NUVB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,932,200 | 683,497 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $6,157,560 | 687,228 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $2,693,206 | 727,894 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,304,186 | 668,814 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $913,203 | 518,867 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,379,408 | 518,575 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,155,010 | 504,372 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,830,560 | 626,905 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,708,592 | 469,394 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $782,336 | 518,104 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $692,249 | 516,604 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $929,496 | 516,387 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $755,563 | 455,159 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $901,170 | 469,360 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $986,771 | 440,523 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,297,514 | 400,468 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,584,610 | 491,371 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $4,172,377 | 490,868 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,816,697 | 283,370 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $1,383,214 | 148,573 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $252,054 | 24,120 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||